Mohamed Hassan | Tumor prevention and Therapy | Best Paper Award

Assist. Prof. Dr Mohamed Hassan | Tumor prevention and Therapy | Best Paper Award

Senior researcher, Tulane university school of medicine, United States

Mohamed Hassan is a distinguished researcher specializing in molecular oncology and translational medicine. He earned his Ph.D. from the University Hospital of Düsseldorf, Germany, focusing on Hepatitis C virus interactions with intracellular signaling. With extensive postdoctoral training in gastroenterology, pathology, and molecular tumor therapy, he has held academic positions in leading institutions across Germany, France, and the USA. His research spans cancer progression, drug resistance, and the tumor microenvironment, contributing to high-impact publications. Recognized globally for his scientific excellence, he has received prestigious awards, including the Italian Ministry of Health Award and the Japanese Society of Internal Medicine Award.

PROFESSIONAL PROFILE

Orcid

EDUCATION

  • Ph.D. (2001), University Hospital of Düsseldorf, Germany – Research on Hepatitis C virus core protein interference in liver cells.
  • M.Sc. (1996), University of Düsseldorf, Germany – Study on cDNA expression in malaria-immune mice.
  • B.Sc. (1983), Zagazig University & University of Düsseldorf, Germany.
  • Further Training: Teaching certification (University of Mississippi Medical Center, 2015), Clinical Research Associate (Germany, 2011), eLearning applications (University of Köln, 2008), and animal experimentation training (University of Düsseldorf, 2005).

EXPERIENCE

  • Senior Postdoctoral Fellow & PI – Institut National de la Santé et de la Recherche Médicale, University of Strasbourg (2007-2013).
  • Research Assistant Professor – Tulane University, USA (2016-2018); University of Strasbourg, France (2018-present).
  • Instructor – University of Mississippi Medical Center (2013-2016).
  • Postdoctoral Fellow – University Hospital of Düsseldorf (2001-2004).
  • Research Assistant – University Hospital of Düsseldorf (1996-2001); University of Düsseldorf (1992-1996).

AWARDS AND HONORS

🏅 2016 – Italian Ministry of Health Award for Research & Innovation.
🏅 2016 – Award of Excellence in Reviewing by Spandido Publications.
🏅 2011 – Japanese Society of Internal Medicine Outstanding Researcher Award.

RESEARCH FOCUS

🔬 Cancer Biology – Investigating tumor progression, metastasis, and resistance mechanisms.
🧬 Molecular Oncology – Targeting non-receptor tyrosine kinases in cancer therapy.
💊 Translational Medicine – Developing novel therapeutic strategies against cancer stem-like cells.
🦠 Immuno-oncology – Exploring immune checkpoint inhibitors and their effects.
🧑‍⚕️ Clinical Research – Bridging molecular insights with patient-centered treatments.

PUBLICATIONS

📄 Immune Checkpoint Inhibitor-Associated Cutaneous Adverse EventsInternational Journal of Molecular Sciences (2024)
📄 Non-Receptor Tyrosine Kinases in Tumor Progression and ResistanceCancers (2024)
📄 hTERT Epigenetics & Chemotherapy GuidanceInternational Journal of Molecular Sciences (2024)
📄 CD133-Dependent Activation in Melanoma ProgressionCells (2024)
📄 Mechanisms of Melanoma Progression & Treatment ResistanceCancers (2024)
📄 Tumor Microenvironment as a Therapeutic Target in MelanomaCancers (2023)
📄 Toll-like Receptors in Antimicrobial Protein ExpressionInternational Journal of Molecular Sciences (2023)
📄 Antimicrobial Proteins: Structure & Therapeutic PotentialPharmaceutics (2022)

CONCLUSION

Mohamed Hassan is a leading figure in molecular oncology, contributing groundbreaking research in cancer progression and therapy resistance. His work has been recognized internationally, and he continues to drive impactful discoveries in translational medicine and immuno-oncology. His commitment to scientific excellence is evident in his numerous high-impact publications and global collaborations. 🚀

SO JUNG LEE – clinical oncology – Women Researcher Award

SO JUNG LEE - clinical oncology - Women Researcher Award

Catholic university of Korea - South Korea

AUTHOR PROFILE

SCOPUS

🎓 EDUCATIONAL BACKGROUND

SO JUNG LEE, born on March 1, 1988, in South Korea, pursued her medical education at Konyang University College of Medicine, where she obtained her MD in 2012. She later completed her Ph.D. at the Catholic University Graduate School in Seoul, Korea, in 2019, specializing in radiation oncology. Her academic journey has equipped her with a strong foundation in medical sciences, particularly in the field of oncology.

🏥 CURRENT POSITION

Since 2022, Dr. So Jung Lee has been serving as a Clinical Assistant Professor in the Department of Radiation Oncology at Incheon St. Mary's Hospital, part of the College of Medicine at the Catholic University of Korea. In this role, she actively contributes to the advancement of cancer treatment and patient care through her clinical expertise and research endeavors.

🧑‍⚕️ PROFESSIONAL TRAINING

Dr. Lee's professional training includes a residency in the Department of Radiation Oncology at the Catholic Medical Center in Seoul. She further honed her skills through fellowships at Incheon St. Mary’s Hospital and Seoul St. Mary’s Hospital, gaining extensive experience in radiation oncology. Her comprehensive training has made her a key figure in the field.

🔬 RESEARCH AND PUBLICATIONS

Dr. Lee has made significant contributions to the field of radiation oncology through her research. She has authored several influential publications, including studies on the clinical course of late toxicity in cervical cancer radiotherapy and the impact of boost radiation therapy after hysterectomy. Her work has been published in reputable journals like Medicina, Strahlentherapie und Onkologie, and Clinical and Translational Oncology.

🌐 INTERNATIONAL COLLABORATIONS

Dr. Lee has engaged in international collaborations, enhancing her research through partnerships with global institutions. Her work on nasopharyngeal cancer and the efficacy of MRI-guided radiotherapy for HCC patients has been recognized internationally, contributing to the global understanding of cancer treatment.

💉 CLINICAL FOCUS

Her clinical focus includes treating various cancers, with a particular interest in advanced radiation therapy techniques. Dr. Lee has been involved in studies assessing the efficacy and safety of novel radiotherapy approaches, aiming to improve patient outcomes and reduce treatment-related toxicity.

📚 TEACHING AND MENTORSHIP

In addition to her clinical and research roles, Dr. Lee is passionate about education. She actively teaches medical students and residents at the Catholic University of Korea, sharing her knowledge in radiation oncology and guiding the next generation of medical professionals.

NOTABLE PUBLICATION

Re-Irradiation with Intensity-Modulated Radiation Therapy for the Treatment of Recurrent Cervical Cancer in the Pelvis: An Analysis of Outcomes and Toxicity
Authors: Kang, H.J., Kwak, Y.-K., Lee, S.J., Kim, M.
Year: 2023

Application of Real-Time MRI-Guided Linear Accelerator in Stereotactic Ablative Body Radiotherapy for Non-Small Cell Lung Cancer: One Step Forward to Precise Targeting
Authors: Kang, H.J., Kwak, Y.-K., Kim, M., Lee, S.J.
Year: 2022
Journal: Journal of Cancer Research and Clinical Oncology

MRI-Guided Radiotherapy for PVTT in HCC Patients: Evaluation of the Efficacy and Safety
Authors: Lee, S.J., Kim, M., Kwak, Y.-K., Kang, H.J.
Year: 2022
Journal: Journal of Cancer Research and Clinical Oncology

Linear Tumor Regression of Rectal Cancer in Daily MRI during Preoperative Chemoradiotherapy: An Insight of Tumor Regression Velocity for Personalized Cancer Therapy
Authors: Sung, S.-Y., Lee, S.-W., Hong, J.H., Kim, J.-H., Kwak, Y.-K.
Year: 2022
Journal: Cancers

Clinical Outcome and Toxicity of Radiotherapy for Inferior Vena Cava Tumor Thrombus in HCC Patients: A Retrospective Study
Authors: Lee, S.J., Jang, H.S., Choi, Y.K., Sun, Y.X.
Year: 2021
Journal: Medicine (United States)